Literature DB >> 17939316

Sickle cell anaemia: is it a cause for secondary osteoporosis?

M Sadat-Ali1, A H Al Elq.   

Abstract

OBJECTIVE: The risk of osteoporosis and osteopenia i s patients with sickle cell anaemia is not well established. This prospective study was conducted to assess the prevalence of osteoporosis and osteopenia in sickle cell anaemia.
METHODS: Consecutive adult sickle cell anaemia patients who were treated at the department of orthopaedic surgery of King Fahd University Hospital, AIKhobar, SaudiArabia, between April and July 2006, were the subjects of study. After a verbal consent to participate in the study, patients age and sex were documented and body mass index (BMI) was calculated. Blood was extracted for haematological and biochemistry which also included haemoglobin electrophoresis. Bone mineral density (BMD) measurement was done using dual energy x-rayabsorbtiometry (DEXA) at the lumbar spine and the upper femur. Osteopenia and osteoporosis was diagnosed as per the WHO criteria.
RESULTS: The results of 36 patients were analyzed. There were 23 males and 13 females. The average age in males was 34.21+/-6.35 years, and females was 35.38+/-5.40 years. Eighty-two percent of males and 76% of the females were either osteopenic or osteoporotic. The prevalence of osteoporosis in males was highest at lumbar spine (P= 0.001).
CONCLUSIONS: This study finds the prevalence of osteopenia and osteoporosis is quite high among Saudi adult SCA patients. Physicians should be aware of the risk of osteoporosis in sickle cell patients and every effort should be made to treat them adequately and prevent osteoporosis related fractures.

Entities:  

Mesh:

Year:  2007        PMID: 17939316

Source DB:  PubMed          Journal:  West Afr J Med        ISSN: 0189-160X


  7 in total

1.  Evaluation of panoramic radiomorphometric indices related to low bone density in sickle cell disease.

Authors:  F S Neves; L S A F Oliveira; M G G Torres; M B P Toralles; M C B O da Silva; M I G Campos; P S F Campos; I Crusoé-Rebello
Journal:  Osteoporos Int       Date:  2011-10-18       Impact factor: 4.507

2.  Rheumatoid arthritis in patient with homozygous haemoglobin C disease.

Authors:  Sanae Ali Ou Alla; Fadoua Allali; Najia Hajjaj-Hassouni
Journal:  Rheumatol Int       Date:  2009-10-25       Impact factor: 2.631

3.  Fracture prevalence and relationship to endocrinopathy in iron overloaded patients with sickle cell disease and thalassemia.

Authors:  Ellen B Fung; Paul R Harmatz; Meredith Milet; Thomas D Coates; Alexis A Thompson; Mark Ranalli; Robert Mignaca; Charles Scher; Patricia Giardina; Shanda Robertson; Lynne Neumayr; Elliott P Vichinsky
Journal:  Bone       Date:  2008-03-15       Impact factor: 4.398

Review 4.  Clinical Impact and Cellular Mechanisms of Iron Overload-Associated Bone Loss.

Authors:  Viktória Jeney
Journal:  Front Pharmacol       Date:  2017-02-21       Impact factor: 5.810

5.  Osteoporosis prophylaxis in patients receiving chronic glucocorticoid therapy.

Authors:  Mir Sadat-Ali; Abdulmohsen H Alelq; Badar A Alshafei; Haifa A Al-Turki; Mohammed A Abujubara
Journal:  Ann Saudi Med       Date:  2009 May-Jun       Impact factor: 1.526

Review 6.  An epidemiological analysis of the incidence of osteoporosis and osteoporosis-related fractures among the Saudi Arabian population.

Authors:  Mir Sadat-Ali; Ibrahim M Al-Habdan; Haifa A Al-Turki; Mohammed Quamar Azam
Journal:  Ann Saudi Med       Date:  2012 Nov-Dec       Impact factor: 1.526

Review 7.  Influence of Iron on Bone Homeostasis.

Authors:  Enikő Balogh; György Paragh; Viktória Jeney
Journal:  Pharmaceuticals (Basel)       Date:  2018-10-18
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.